Open AccessSeroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases
Author(s) -
Tali Eviatar,
Victoria Furer,
Ari Polachek,
David Levartovsky,
Ofir Elalouf,
Michael Zisapel,
Tamar Halperin,
Dan Turner,
Daphna Paran,
Sara Pel,
Sharon Nevo,
Ori Elkayam
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/ykin5p
Subject(s) - medicine , seroprevalence , serology , rheumatology , immunology , antibody , gastroenterology
To assess the prevalence of anti-SARS-CoV-2 antibodies in autoimmune inflammatory rheumatic disease (AIIRD) patients, and to define clinical factors associated with seropositivity.